Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Whitney Brown A"'
Autor:
Ostrenga, Joshua S., Whitney Brown, A., Todd, Jonathan V., Elbert, Alexander, Fink, Aliza K., Faro, Albert, Marshall, Bruce C., Cromwell, Elizabeth A.
Publikováno v:
In Annals of Epidemiology October 2023 86:98-103
Autor:
Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e18618- (2023)
Rationale and objectives: Lung transplantation is a potentially life-saving treatment option for patients with idiopathic pulmonary fibrosis (IPF); however, not all eligible candidates get referred and listed for transplantation. Amongst IPF patients
Externí odkaz:
https://doaj.org/article/8c37b2bb0a4644b09df9db233129b2fc
Autor:
Christopher Thomas, Abhimanyu Chandel, Christopher S. King, Shambhu Aryal, A. Whitney Brown, Vikramjit Khangoora, Alan Nyquist, Anju Singhal, Onix Cantres Fonseca, Oksana Shlobin, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract COVID‐19 related lung disease (CRLD) has emerged as an indication for lung transplantation (LT) in highly select patients. The prevalence and prognostic implication of coexisting pulmonary hypertension (PH) in patients with CRLD listed for
Externí odkaz:
https://doaj.org/article/6ee5e7f16f584fdfb562f8b88c9b069e
Autor:
Ganesh Raghu, Mark J. Hamblin, A. Whitney Brown, Jeffrey A. Golden, Lawrence A. Ho, Marlies S. Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E. Antin-Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF) during the 28-
Externí odkaz:
https://doaj.org/article/2c195c019cfe4de6992fd1e22d59cc6f
Autor:
Shourjo Chakravorty, MD, Adam B. Cochrane, PharmD, MPH, Mitchell A. Psotka, MD, PhD, Anil Regmi, MD, Lauren Marinak, NP, Amy Thatcher, NP, Oksana A. Shlobin, MD, A. Whitney Brown, MD, Christopher S. King, MD, FCCP, Kareem Ahmad, MD, Vikramjit Khangoora, MD, Anju Singhal, MD, Steven D. Nathan, MD, FCCP, Shambhu Aryal, MD, FCCP
Publikováno v:
Transplantation Direct, Vol 8, Iss 7, p e1344 (2022)
Externí odkaz:
https://doaj.org/article/b3cf188fe88248bdacf87d2d07191192
Autor:
Jean Pastre, Scott Barnett, Inga Ksovreli, Jeannie Taylor, A. Whitney Brown, Oksana A. Shlobin, Kareem Ahmad, Vikramjit Khangoora, Shambhu Aryal, Christopher S. King, Steven D. Nathan
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Research question There is no widely accepted grading system for IPF disease severity, although physiologic impairment based on pulmonary function testing is frequently employed. We sought to describe clinical and functional characteristics
Externí odkaz:
https://doaj.org/article/957b6d8409f64957b06be2e055fe2a32
Autor:
Franck F. Rahaghi, Zeenat Safdar, Anne Whitney Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand, Adrian Shifren, Steven D. Nathan
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background In patients with idiopathic pulmonary fibrosis (IPF) treated with pirfenidone (Esbriet®, Genentech USA, Inc. South San Francisco, CA.), effectively managing treatment-related adverse events (AEs) may improve adherence. Due to a l
Externí odkaz:
https://doaj.org/article/d0b1eef6d42344f291d481150205b102
Autor:
Abhimanyu Chandel, Saloni Patolia, Kareem Ahmad, Shambhu Aryal, A Whitney Brown, Dhwani Sahjwani, Vikramjit Khangoora, Oksana A Shlobin, Paula C Cameron, Anju Singhal, Arthur W Holtzclaw, Mehul Desai, Steven D Nathan, Christopher S King
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 15 (2021)
INTRODUCTION Limited evidence exists regarding use of inhaled nitric oxide (iNO) in spontaneously breathing patients. We evaluated the effectiveness of continuous iNO via high-flow nasal cannula (HFNC) in COVID-19 respiratory failure. METHODS We perf
Externí odkaz:
https://doaj.org/article/79e24b7c9d634d4a8db0e15885692726
Publikováno v:
BMJ case reports. 14(12)
We present the first reported case of
Autor:
Abhimanyu Chandel, Alison Verster, Husna Rahim, Vikramjit Khangoora, Steven D. Nathan, Kareem Ahmad, Shambhu Aryal, Aaron Bagnola, Anju Singhal, A. Whitney Brown, Oksana A. Shlobin, Christopher S. King
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
It has been suggested pleural effusions may develop in right heart failure in the absence of left heart disease. The incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension is uncertain. Patients with pulmonary a
Externí odkaz:
https://doaj.org/article/c07bd95ca0354aa1881c88a6549a0052